Log In
BCIQ
Print this Print this
 

FSME-Immun

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionTick-borne encephalitis vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationEncephalitis
Indication DetailsPrevent tick-borne encephalitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$635.0M

$635.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/30/2014

$635.0M

$635.0M

0

Get a free BioCentury trial today